Higher API and FD sales drove the numbers Granules (Inc) is a leading generic player in the Indian pharmaceutical industry with 2/3rd of its revenue generated from North America and Europe and the rest accomplished from Emerging markets like India. Q2FY19 revenue grew by 47% YoY driven by higher sales in API...